Atlas Trials

IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM

Clinical trial NCT04003649 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04003649
Sponsor
City of Hope Medical Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Recurrent GlioblastomaRefractory Glioblastoma
Start date
2019-12-02
Primary completion
2024-12-18
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.